vs
Esquire Financial Holdings, Inc.（ESQ）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Esquire Financial Holdings, Inc.的1.7倍（$69.8M vs $40.5M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 30.2%，领先353.9%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 15.0%）
Esquire Financial Holdings是一家总部位于美国的银行控股公司，提供全面的商业及零售银行服务，核心业务包含存款账户、企业贷款、按揭服务及财富管理解决方案，主要服务中小型企业、法律行业从业者及当地零售客户。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
ESQ vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.7倍
$40.5M
净利率更高
RIGL
高出353.9%
30.2%
两年增速更快
RIGL
近两年复合增速
15.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $40.5M | $69.8M |
| 净利润 | $12.2M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | — | 33.2% |
| 净利率 | 30.2% | 384.0% |
| 营收同比 | — | 21.2% |
| 净利润同比 | 7.0% | 1769.2% |
| 每股收益（稀释后） | $1.40 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESQRIGL
| Q1 26 | $40.5M | — | ||
| Q4 25 | $39.4M | $69.8M | ||
| Q3 25 | $37.6M | $69.5M | ||
| Q2 25 | $35.8M | $101.7M | ||
| Q1 25 | $33.8M | $53.3M | ||
| Q4 24 | $33.1M | $57.6M | ||
| Q3 24 | $31.9M | $55.3M | ||
| Q2 24 | $30.6M | $36.8M |
净利润ESQRIGL
| Q1 26 | $12.2M | — | ||
| Q4 25 | $13.5M | $268.1M | ||
| Q3 25 | $14.1M | $27.9M | ||
| Q2 25 | $11.9M | $59.6M | ||
| Q1 25 | $11.4M | $11.4M | ||
| Q4 24 | $11.8M | $14.3M | ||
| Q3 24 | $11.4M | $12.4M | ||
| Q2 24 | $10.5M | $-1.0M |
毛利率ESQRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% |
营业利润率ESQRIGL
| Q1 26 | — | — | ||
| Q4 25 | 44.3% | 33.2% | ||
| Q3 25 | 46.5% | 40.9% | ||
| Q2 25 | 42.5% | 60.1% | ||
| Q1 25 | 45.9% | 23.9% | ||
| Q4 24 | 47.4% | 28.9% | ||
| Q3 24 | 48.8% | 25.4% | ||
| Q2 24 | 46.9% | 1.2% |
净利率ESQRIGL
| Q1 26 | 30.2% | — | ||
| Q4 25 | 34.2% | 384.0% | ||
| Q3 25 | 37.4% | 40.2% | ||
| Q2 25 | 33.2% | 58.6% | ||
| Q1 25 | 33.8% | 21.5% | ||
| Q4 24 | 35.6% | 24.9% | ||
| Q3 24 | 35.6% | 22.5% | ||
| Q2 24 | 34.3% | -2.8% |
每股收益（稀释后）ESQRIGL
| Q1 26 | $1.40 | — | ||
| Q4 25 | $1.54 | $14.11 | ||
| Q3 25 | $1.62 | $1.46 | ||
| Q2 25 | $1.38 | $3.28 | ||
| Q1 25 | $1.33 | $0.63 | ||
| Q4 24 | $1.35 | $0.82 | ||
| Q3 24 | $1.34 | $0.70 | ||
| Q2 24 | $1.25 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $222.2M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $301.3M | $391.5M |
| 总资产 | $2.4B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资ESQRIGL
| Q1 26 | $222.2M | — | ||
| Q4 25 | $235.9M | $155.0M | ||
| Q3 25 | $240.8M | $137.1M | ||
| Q2 25 | $163.0M | $108.4M | ||
| Q1 25 | $173.0M | $77.1M | ||
| Q4 24 | $126.3M | $77.3M | ||
| Q3 24 | $147.7M | $61.1M | ||
| Q2 24 | $152.7M | $49.1M |
总债务ESQRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M |
股东权益ESQRIGL
| Q1 26 | $301.3M | — | ||
| Q4 25 | $289.6M | $391.5M | ||
| Q3 25 | $279.2M | $117.6M | ||
| Q2 25 | $263.6M | $81.9M | ||
| Q1 25 | $250.7M | $18.6M | ||
| Q4 24 | $237.1M | $3.3M | ||
| Q3 24 | $232.6M | $-14.6M | ||
| Q2 24 | $217.4M | $-29.9M |
总资产ESQRIGL
| Q1 26 | $2.4B | — | ||
| Q4 25 | $2.4B | $513.6M | ||
| Q3 25 | $2.2B | $242.5M | ||
| Q2 25 | $2.1B | $206.7M | ||
| Q1 25 | $2.0B | $176.0M | ||
| Q4 24 | $1.9B | $164.0M | ||
| Q3 24 | $1.8B | $139.4M | ||
| Q2 24 | $1.7B | $128.4M |
负债/权益比ESQRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ESQRIGL
| Q1 26 | — | — | ||
| Q4 25 | $59.8M | $22.0M | ||
| Q3 25 | $16.8M | $24.0M | ||
| Q2 25 | $10.5M | $30.5M | ||
| Q1 25 | $15.8M | $-893.0K | ||
| Q4 24 | $42.2M | $14.5M | ||
| Q3 24 | $10.5M | $21.7M | ||
| Q2 24 | $7.2M | $302.0K |
自由现金流ESQRIGL
| Q1 26 | — | — | ||
| Q4 25 | $56.7M | — | ||
| Q3 25 | $16.2M | — | ||
| Q2 25 | $9.3M | — | ||
| Q1 25 | $14.7M | — | ||
| Q4 24 | $41.5M | — | ||
| Q3 24 | $10.5M | — | ||
| Q2 24 | $6.9M | — |
自由现金流率ESQRIGL
| Q1 26 | — | — | ||
| Q4 25 | 143.9% | — | ||
| Q3 25 | 43.2% | — | ||
| Q2 25 | 26.0% | — | ||
| Q1 25 | 43.4% | — | ||
| Q4 24 | 125.5% | — | ||
| Q3 24 | 32.8% | — | ||
| Q2 24 | 22.5% | — |
资本支出强度ESQRIGL
| Q1 26 | — | — | ||
| Q4 25 | 8.0% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 3.2% | — | ||
| Q1 25 | 3.4% | — | ||
| Q4 24 | 2.2% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 1.1% | — |
现金转化率ESQRIGL
| Q1 26 | — | — | ||
| Q4 25 | 4.44× | 0.08× | ||
| Q3 25 | 1.19× | 0.86× | ||
| Q2 25 | 0.88× | 0.51× | ||
| Q1 25 | 1.39× | -0.08× | ||
| Q4 24 | 3.59× | 1.01× | ||
| Q3 24 | 0.93× | 1.75× | ||
| Q2 24 | 0.69× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESQ
| Net Interest Income | $34.0M | 84% |
| Noninterest Income | $6.5M | 16% |
RIGL
暂无分部数据
